Tools / Resources
Dec 23, 2017
Article and Study Summary Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Published in: Lancet...
Dec 12, 2017
When: December 12, 2017 @ 9:00AM (2:00 p.m. Abidjan; 4:00 p.m. Johannesburg; 5:00 p.m. Nairobi; 8:00 p.m. Almaty; 8:30 p.m. Yangon) Presented by: Yael Hirsch-Moverman, PhD, MPH ICAP at Columbia...
Nov 21, 2017
When: November 21, 2017 @ 9:00AM (2:00 p.m. Abidjan; 4:00 p.m. Johannesburg; 5:00 p.m. Nairobi; 8:00 p.m. Almaty; 8:30 p.m. Yangon) Presented by: Nandita S. Sugandhi, MD Elaine J. Abrams, MD ICAPÂ at Columbia...
Nov 2, 2017
Article and Study Summary Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial Published in: Lancet HIV. 2017 Oct 3. DOI: http://dx.doi.org/10.1016/S2352-3018(17)30156-X Authors: Bekker...
Oct 24, 2017
When: October 24, 2017 @ 9:00AM (2:00 p.m. Cote d’Ivoire; 4:00 p.m. Johannesburg; 4:00 p.m. Nairobi; 8:00 p.m. Almaty; 8:30 p.m. Yangon) Presented by: Dr. Wafaa El-Sadr and Dr. Maria Lahuerta ICAP at Columbia...